The ACR’s strict ethical policy guides relationships with pharmaceutical and medical device manufacturers
ACR/ARHP and REF Strategic Planning
Where are we going and how are we going to get there?
A New Focus of International Rheumatology
International collaboration through ILAR promotes health equity in rheumatology
Quality Advice from Specialty Societies
The ACR’s Quality Stakeholders’ Summit explored quality initiatives from several medical societies
Letters to the Editor
I read with interest Dr. Fox’s perspective in the June issue of The Rheumatologist [TR] regarding ghost writing in medical research. Dr. Fox is all for integrity in research (who isn’t?); nevertheless, he takes to task some of the people (Ross et al and the editors of the Journal of the American Medical Association [JAMA]) who write about the corrupting influence of industry on physicians, including those in academics [JAMA 2008;299(15):1800-1812]. Part of his motivation may be to defend members of ACR who have been involved in the activity of ghostwriting and guest editing. This approach may play well to readers of The Rheumatologist, but it would seem that Dr. Fox should address his concerns to the editors of JAMA. That way, the authors of the article could offer a rebuttal to Dr. Fox’s concerns and assertions, and we all could get closer to the truth about this important issue.
Let the ACR Help You Improve Your Practice
Today’s rheumatology practices face increasing internal and external pressures. Staffing effectiveness and efficiency, overhead increases, coding and billing issues, litigious employees, conflicts with colleagues, new competition, changing patient attitudes, new revenue constraints, and managed care contracting and compliance are just some of the pressures that constantly push practices to their limits.
A Workforce for the Future
The ACR is working hard to meet tomorrow’s needs
Science from our Sisters
Recommended reading from AC&R
The Pathway to Success
Collaboration with our partners is key to ensuring a bright future for the ACR
REF and AF Partner to Provide an Additional “Bridge Funding”
Fostering promising investigators is imperative to the future of rheumatology, so when the ACR Research and Education Foundation (REF) board of directors discovered that outstanding applicants were not being funded through the National Institutes of Health (NIH) K-series grant program (the NIH’s career development award program) due to budgetary constraints, the REF quickly called a meeting with the Arthritis Foundation (AF) and the NIH to discuss a solution.
- « Previous Page
- 1
- …
- 45
- 46
- 47
- 48
- 49
- …
- 54
- Next Page »